1 - 20 toradh á dtaispeáint as 45 toradh san iomlán ar an gcuardach 'T.  Yu.  Semiglazova', am iarratais: 0.04s Beachtaigh na torthaí
  1. 1
    CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER

    CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER de réir E. N. Imyanitov, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2017-12-01
    Faigh an téacs iomlán
    Alt
  2. 2
    PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER

    PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER de réir N. A. Kozyavin, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2018-08-01
    Faigh an téacs iomlán
    Alt
  3. 3
    Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer

    Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer de réir V. A. Kostorov, T. Yu. Semiglazova, A. V. Pavlysh

    Foilsithe / Cruthaithe 2018-07-01
    Faigh an téacs iomlán
    Alt
  4. 4
    DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST

    DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST de réir T. Yu. Semiglazova, G. M. Teletaeva, N. A. Kozyavin, A. V. Zagatina

    Foilsithe / Cruthaithe 2017-09-01
    Faigh an téacs iomlán
    Alt
  5. 5
    The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state

    The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state de réir T. Yu. Semiglazova, N. A. Brish, T. Yu. Galunova, A. S. Bernatskiy, V. V. Semiglazov

    Foilsithe / Cruthaithe 2018-07-01
    Faigh an téacs iomlán
    Alt
  6. 6
    Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors

    Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors de réir Van Shu, A. S. Artemieva, E. A. Busco, V. V. Semiglazov, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2017-05-01
    Faigh an téacs iomlán
    Alt
  7. 7
    The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study)

    The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study) de réir V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev

    Foilsithe / Cruthaithe 2023-10-01
    Faigh an téacs iomlán
    Alt
  8. 8
    Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer

    Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer de réir T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

    Foilsithe / Cruthaithe 2014-07-01
    Faigh an téacs iomlán
    Alt
  9. 9
    Features of nutritional support during stem cell transplantation

    Features of nutritional support during stem cell transplantation de réir S. A. Volchenkov, L. V. Filatova, E. V. Cherkasova, A. K. Koviazin, S. V. Lyubimov, I. S. Zyuzgin, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2020-07-01
    Faigh an téacs iomlán
    Alt
  10. 10
    General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)

    General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) de réir V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

    Foilsithe / Cruthaithe 2015-09-01
    Faigh an téacs iomlán
    Alt
  11. 11
    Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment

    Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment de réir V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

    Foilsithe / Cruthaithe 2018-07-01
    Faigh an téacs iomlán
    Alt
  12. 12
    International rehabilitation model for oncological patients

    International rehabilitation model for oncological patients de réir T. Yu. Semiglazova, V. A. Klyuge, B. S. Kasparov, K. O. Kondratyeva, A. A. Krutov, M. A. Zernova, V. A. Chulkova, V. V. Semiglazov

    Foilsithe / Cruthaithe 2018-07-01
    Faigh an téacs iomlán
    Alt
  13. 13
    2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance

    2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance de réir V. A. Alexandrov, G. V. Tochilnikov, S. V. Shatik, A. N. Stukov, O. A. Beljaeva, E. V. Bashkatova, V. G. Dranishnikov, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2025-01-01
    Faigh an téacs iomlán
    Alt
  14. 14
    Activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propandyоl (chlonisol) versus lomustine in intracranial transplanted tumor model in mice

    Activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propandyоl (chlonisol) versus lomustine in intracranial transplanted tumor model in mice de réir Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2022-12-01
    Faigh an téacs iomlán
    Alt
  15. 15
    The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma

    The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma de réir Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova

    Foilsithe / Cruthaithe 2023-04-01
    Faigh an téacs iomlán
    Alt
  16. 16
    Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma

    Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma de réir I. G. Murazov, A. N. Stukov, Iu. G. Zmitrichenko, A. O. Niuganen, G. V. Tochilnikov, D. Ch. Latipova, L. V. Filatova, T. Yu. Semiglazova

    Foilsithe / Cruthaithe 2021-09-01
    Faigh an téacs iomlán
    Alt
  17. 17
    Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer

    Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer de réir R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova

    Foilsithe / Cruthaithe 2023-06-01
    Faigh an téacs iomlán
    Alt
  18. 18
    Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction

    Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction de réir A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko

    Foilsithe / Cruthaithe 2024-04-01
    Faigh an téacs iomlán
    Alt
  19. 19
    Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma

    Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma de réir E. V. Kharchenko, T. Yu. Semiglazova, A. S. Artem’yeva, G. S. Kireyeva, I. L. Polyatskin, I. S. Zyuzgin, L. V. Filatova, Yu. A. Chudinovskikh, M. S. Motalkina, Yu. A. Oleynik

    Foilsithe / Cruthaithe 2019-12-01
    Faigh an téacs iomlán
    Alt
  20. 20
    Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

    Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... de réir E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

    Foilsithe / Cruthaithe 2017-02-01
    Faigh an téacs iomlán
    Alt

Uirlisí cuardaigh: